Liberto Erin 4
4 · AVITA Medical, Inc. · Filed Sep 7, 2021
Insider Transaction Report
Form 4
Liberto Erin
Chief Commercial Officer
Transactions
- Award
Common Stock
2021-07-06+10,500→ 10,500 total - Award
Stock Options (Right to Buy)
2021-05-18+6,000→ 30,000 totalExercise: $5.03Exp: 2027-09-06→ Common Stock (6,000 underlying) - Award
Stock Options (Right to Buy)
2021-07-06+6,925→ 6,925 totalExercise: $20.21Exp: 2031-07-06→ Common Stock (6,925 underlying)
Footnotes (3)
- [F1]Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.
- [F2]These Stock Options were originally granted on September 6, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.
- [F3]These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.